Pawomics Recognized as Finalist for CHFA Launch Pad 2024 – “Most Innovative Product”
Vancouver, BC — March 8, 2024 — Pawomics, a Canadian biotechnology company specializing in pet microbiome and genomic health, has been named one of the Top 8 Finalists in the Canadian Health Food Association (CHFA) Launch Pad 2024 Competition, recognizing its product Probiotics4Dogs Powder as one of the nation’s most innovative wellness solutions.
Hosted at CHFA NOW Vancouver, the Launch Pad competition celebrates the next generation of brands driving innovation in health and wellness. Pawomics stood out as one of the only pet-focused finalists, marking a milestone moment for the growing field of microbiome-based pet health in Canada.
“We’re honoured to represent Canadian innovation in the pet health sector,” said the Pawomics team. “Probiotics4Dogs Powder reflects years of microbiome research and a deep commitment to bringing real science into pet care — helping pets live healthier, happier lives from the inside out.”
Science-Driven Innovation for Pets
Pawomics’ Probiotics4Dogs Powder is formulated using scientifically selected probiotic strains that restore microbial balance in the gut, support immune health, and improve digestion. The formulation is based on Pawomics’ proprietary microbiome research platform, which combines genomics, microbial ecology, and data analytics to deliver evidence-based solutions tailored for companion animals.
A Milestone for Canadian Pet Biotechnology
The CHFA Launch Pad is one of Canada’s most respected industry competitions, highlighting groundbreaking natural health products across the country. Pawomics’ recognition reinforces Canada’s leadership in the intersection of biotechnology and animal wellness, a sector rapidly expanding through innovation in microbiome research.
“This recognition validates our mission to bridge science and compassion,” said the Pawomics founders. “We believe the same scientific precision used in human wellness should also benefit the pets who share our lives.”
About Pawomics
Founded in Canada, Pawomics is a division of Funomics Global Inc., a biotechnology company committed to improving pet health through genomics and microbiome science. Pawomics develops microbiome testing kits and probiotic, prebiotic, and postbiotic supplements that promote gut, skin, and overall health for dogs and cats.
Mission: Treat Pets Differently, with Canadian Innovation
Learn more at www.pawomics.ca or follow @pawomics on Instagram.
